Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.42B | 25.58B | 44.98B | 18.73B | 43.73B | 39.34B |
Gross Profit | 24.42B | 27.60B | 49.06B | 19.84B | 43.73B | 30.15B |
EBITDA | 5.12B | 5.11B | 3.22B | 3.04B | 2.55B | 1.61B |
Net Income | 2.26B | 1.98B | 1.58B | 706.00M | 1.01B | 648.00M |
Balance Sheet | ||||||
Total Assets | 177.29B | 180.42B | 168.53B | 193.13B | 197.52B | 181.04B |
Cash, Cash Equivalents and Short-Term Investments | 120.02B | 123.34B | 5.10B | 95.53B | 106.21B | 97.74B |
Total Debt | 7.84B | 8.90B | 9.11B | 9.78B | 7.65B | 6.19B |
Total Liabilities | 159.04B | 161.92B | 151.73B | 180.54B | 179.58B | 163.91B |
Stockholders Equity | 11.85B | 11.66B | 10.45B | 8.64B | 10.78B | 10.39B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 8.43B | 7.63B | 5.77B | 8.38B | 5.87B |
Operating Cash Flow | 0.00 | 8.43B | 8.10B | 5.97B | 10.05B | 6.32B |
Investing Cash Flow | 0.00 | -6.79B | -5.03B | -6.86B | -10.06B | -5.01B |
Financing Cash Flow | 0.00 | -1.58B | -1.49B | 521.00M | 428.00M | -1.03B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €32.10B | 12.93 | 22.81% | 3.35% | 7.50% | 22.49% | |
74 Outperform | €142.67B | 13.79 | 19.77% | 4.17% | 47.32% | 17.07% | |
71 Outperform | €74.83B | 14.81 | 16.65% | 3.53% | 2.36% | -11.93% | |
68 Neutral | €29.41B | 13.01 | 19.75% | 2.34% | 6.51% | 22.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | €767.23M | ― | -0.95% | 0.20% | -1.28% | -153.13% | |
64 Neutral | €1.31B | 38.57 | 0.69% | 4.46% | 4.19% | -75.44% |